Soliqua® Solostar Pens for Type 2 Diabetes

This combination pen pairs long-acting insulin glargine with lixisenatide for adults with type 2 diabetes. It helps improve fasting and after-meal glucose when diet and exercise are not enough. This page explains how to buy insulin glargine lixisenatide pen, compares options, and outlines access, including choices without insurance, with US shipping from Canada.

What Soliqua Is and How It Works

Soliqua® contains basal insulin glargine and the GLP-1 receptor agonist lixisenatide. The insulin component lowers fasting glucose by providing steady background coverage. The GLP-1 component helps control post-meal spikes by slowing gastric emptying and increasing glucose-dependent insulin release.

CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

This medicine is taken once daily before the first meal. It is intended to be used with diet and exercise. Do not combine it with other GLP-1 receptor agonists or with mealtime insulin. It is not for type 1 diabetes or for treating diabetic ketoacidosis.

For a device overview, see Dual Action Support.

Who It’s For

The treatment is for adults with type 2 diabetes who need better control on basal insulin alone, a GLP-1 therapy alone, or oral agents. It may be appropriate when fasting and post-meal readings remain above target despite lifestyle measures.

Do not use it for type 1 diabetes. Avoid if you have a history of serious hypersensitivity to insulin glargine or lixisenatide. People with severe gastrointestinal disease, especially gastroparesis, should not use a GLP-1 agent. Your clinician will assess kidney function and overall risks.

Learn more about the condition at Type 2 Diabetes.

Dosage and Usage

Use this medicine once daily within the hour before your first meal. Inject subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites with each dose. Follow the dose your prescriber selects based on your prior basal insulin use and treatment history.

General label guidance includes starting at a low dose and adjusting stepwise to reach fasting glucose goals. Titration should be cautious to reduce hypoglycemia and gastrointestinal effects. Never share pens. Do not inject into a vein or muscle.

If your clinician transitions you from standalone basal insulin or a GLP-1 agent, the starting dose and schedule come from the official label. When unsure, consult that label and your prescriber rather than changing any dose yourself.

For device landscape and technique refreshers, see Diabetes Tech and browse Insulin Pens.

Strengths and Forms

The pen is a prefilled disposable device. Each pack typically contains five 3 mL pens. Many patients know this as the Soliqua Solostar 100/33 prefilled pen.

Availability can vary by pharmacy and by region. Packaging and device color may differ from images. Confirm the pen type on the carton before use.

Missed Dose and Timing

If you miss a dose, skip it and take your next dose at the usual time the following day. Do not take two doses on the same day. If you are uncertain, follow the official label and ask your healthcare professional.

Storage and Travel Basics

Before first use, store unopened pens in the refrigerator. Do not freeze. Keep away from light. After first use, most pens may be kept at room temperature for a limited time per the label. Discard the pen after the in-use period ends, even if insulin remains.

Keep the cap on when not in use. Do not store with a needle attached. Protect from heat during travel. Use a protective case and carry a backup pen when possible. Bring your prescription or a travel letter if crossing borders. A micro trust cue: encrypted checkout supports secure ordering.

Pen Handling and Sharps Disposal

Wash hands. Attach a new needle for each injection. Prime the pen as directed before the first dose of a new pen. Dial the selected dose. Insert the needle into the skin, press the button, and hold for several seconds to ensure full delivery. Remove the needle and dispose of it in an appropriate sharps container.

Rotate injection sites to reduce skin issues. Never share your pen or needles. Follow local rules for sharps disposal or use a mail-back program.

Benefits

This medicine simplifies therapy by combining basal insulin with a GLP-1 agent in one daily injection. It can reduce fasting and after-meal glucose with a single device. Many patients appreciate dose titration using one pen and reduced injection burden compared with separate products.

Side Effects and Safety

• Common: nausea, vomiting, diarrhea
• Injection site redness or itching
• Headache or dizziness
• Decreased appetite or a feeling of fullness

Hypoglycemia can occur, especially if meals are delayed, activity increases, or you use other glucose-lowering medicines. Severe allergic reactions are rare but possible. Pancreatitis has been reported with GLP-1 therapies; seek urgent care for severe, persistent abdominal pain. Kidney issues may worsen with dehydration from vomiting or diarrhea. Discuss risks with your prescriber.

Drug Interactions and Cautions

Using this treatment with sulfonylureas or other insulin may increase hypoglycemia risk. Lixisenatide can slow gastric emptying, which may affect the absorption of some oral medications. Your clinician may ask you to monitor certain drugs more closely. Thiazolidinediones with insulin can cause fluid retention; heart failure may be a concern in susceptible patients.

Alcohol, illness, stress, and changes in activity can alter glucose needs. Always consult the official label for the full interaction list.

What to Expect Over Time

Glucose patterns may improve as you titrate to your target fasting level. Gastrointestinal symptoms, if present, often appear early and may lessen as your body adjusts. Consistent dosing before the first meal, predictable meals, and regular activity support stable control.

Track fasting and post-meal readings according to your care plan. Bring logs to appointments so your clinician can adjust therapy. If your Soliqua Solostar cash price affects adherence, discuss financial options early.

Compare With Alternatives

Some adults may consider another fixed-ratio combination, such as Xultophy® Prefilled Pen. Others may use a long-acting insulin alone, such as Toujeo® Doublestar Prefilled Pen, with a separate mealtime plan if needed. Your prescriber can help select the class and device that fit your goals and prior history. Explore broader options in Long Acting Insulin.

Pricing and Access

We reflect Canadian pricing with transparent product listings. Many patients compare options by insurance status, copays, and pharmacy fees. If you need Soliqua Solostar US shipping, we coordinate secure fulfilment. We also support US delivery from Canada for eligible orders.

To reduce out-of-pocket exposure, check manufacturer assistance programs and ask about multi-pen fills. See current offers at Promotions. If you are researching generic insulin glargine lixisenatide pen price across therapies, note that fixed-ratio combinations are branded products.

Availability and Substitutions

Supply can vary by dose and pack size. If this product is unavailable, your prescriber may recommend a therapeutic alternative from the same or a different class. We will not substitute without your clinician’s guidance and a valid prescription.

For qualified orders, you can purchase Soliqua Solostar pens online after completing the required steps.

Patient Suitability and Cost-Saving Tips

Good candidates are adults with type 2 diabetes who need both basal coverage and post-meal support. It may not suit those with recurrent nausea, gastroparesis, or pancreatitis history. It is not recommended for type 1 diabetes or for diabetic ketoacidosis.

To manage costs, ask about multi-month supplies, refill reminders, and timing refills before travel. Compare coverage policies and preferred pharmacy networks. If affordability is a barrier, discuss community programs and samples with your healthcare professional. You can also review generic insulin glargine lixisenatide pen price discussions with your clinician to understand class options.

Questions to Ask Your Clinician

• Starting dose and how it was selected
• Titration steps and fasting glucose targets
• How to manage nausea or decreased appetite
• Signs of hypoglycemia and what to keep on hand
• Whether other diabetes drugs should be adjusted
• Travel and storage plans for upcoming trips

Authoritative Sources

DailyMed: Soliqua 100/33 Prescribing Information

Manufacturer Product Site

Health Canada Drug Product Database

Pricing and Ordering

Ready to proceed? You can add to cart, upload your prescription, and complete checkout for Ships from Canada to US with express, cold-chain shipping. This content is for general information and does not replace the approved label or your clinician’s advice.